Abstract

275P Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and /or metastatic squamous cell carcinoma of head and neck: A double institution retrospective analysis from India

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and /or metastatic squamous cell carcinoma of head and neck: a retrospective analysis from two institutions in India
M V Chandrakanth ... Harsh Dhar
F1000Research | VOL. 12
M V Chandrakanth, et. al.M V Chandrakanth ... Harsh Dhar
10 Jul 2023
Breakthrough targeted therapeutic approaches to squamous cell carcinoma of the head and neck.
Alberto Mangano ... Georgios D Lianos
Future oncology (London, England) | VOL. 11
Alberto Mangano, et. al.Alberto Mangano ... Georgios D Lianos
09 Jan 2015
Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2).
Tomoya Yokota ... Yosuke Ota
International Journal of Clinical Oncology | VOL. 26
Tomoya Yokota, et. al.Tomoya Yokota ... Yosuke Ota
30 Oct 2020
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
R Hitt ... J.J Cruz-Hernandez
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 23
R Hitt, et. al.R Hitt ... J.J Cruz-Hernandez
01 Apr 2012
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Proofreading the way: immune checkpoint inhibitors in polymerase ε/polymerase δ (POLE/POLD1)-altered colorectal cancer
M Cecchini ... R Sundar
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
M Cecchini, et. al.M Cecchini ... R Sundar
01 Jul 2024
Table of Contents
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
Editorial Board
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
View more papers